RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 99 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $15,370,688 | +144.2% | 374,347 | +157.7% | 0.10% | +136.6% |
| Q1 2024 | $6,295,459 | +10803.5% | 145,291 | +11467.8% | 0.04% | – |
| Q4 2023 | $57,738 | +283.9% | 1,256 | +91.5% | 0.00% | – |
| Q3 2023 | $15,039 | +2431.8% | 656 | +1722.2% | 0.00% | – |
| Q2 2023 | $594 | -99.8% | 36 | -99.8% | 0.00% | -100.0% |
| Q1 2022 | $270,000 | +900.0% | 23,400 | +550.0% | 0.00% | – |
| Q4 2021 | $27,000 | +285.7% | 3,600 | +554.5% | 0.00% | – |
| Q3 2021 | $7,000 | -36.4% | 550 | 0.0% | 0.00% | – |
| Q2 2021 | $11,000 | -8.3% | 550 | 0.0% | 0.00% | – |
| Q1 2021 | $12,000 | -25.0% | 550 | 0.0% | 0.00% | – |
| Q4 2020 | $16,000 | -61.0% | 550 | -71.1% | 0.00% | – |
| Q3 2020 | $41,000 | – | 1,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 735,000 | $13,112,400 | 3.93% |
| NEA Management Company, LLC | 2,909,956 | $51,913,615 | 3.59% |
| Frazier Life Sciences Management, L.P. | 2,164,739 | $38,618,944 | 2.80% |
| RA Capital Management | 5,516,067 | $98,406,635 | 2.23% |
| Samsara BioCapital, LLC | 345,293 | $6,160,027 | 1.27% |
| Rock Springs Capital Management LP | 1,597,123 | $28,492,674 | 0.68% |
| Baker Brothers Advisors | 6,498,267 | $115,929,083 | 0.63% |
| HighVista Strategies LLC | 35,478 | $632,928 | 0.52% |
| Nan Fung Group Holdings Ltd | 32,520 | $580,157 | 0.40% |
| GREAT POINT PARTNERS LLC | 97,544 | $1,740,185 | 0.34% |